This randomized clinical trial compares the effect of morning vs bedtime administration of antihypertensive agents on nocturnal blood pressure control and circadian rhythm among patients with hypertension.
This study uses US Food and Drug Administration (FDA) data to characterize pivotal and confirmatory trials supporting agency decision-making in the context of the FDA…
A new study has revealed promising progress in developing a non-invasive sampling method to detect early signs of Parkinson’s disease—up to seven years before motor…
This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is…
This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is…
This Viewpoint explores the US Food and Drug Administration’s institution of a class Safety Labeling Change for messenger RNA (mRNA) COVID-19 vaccines.
Background From 1918 to 1920, the largest influenza A virus (IAV) pandemic known to date spread globally causing between 20 to 100 million deaths. Historical…
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
This cohort study analyzes electronic health record data for patients with idiopathic intracranial hypertension to assess whether therapy with glucagon-like peptide 1 receptor agonists is…
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
